Why Is The Best Stock Of The Day SIGA Technologies Inc (SIGA)?

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga.

SIGA Technologies is a public, commercial-stage pharmaceutical firm that focuses on health security solutions. With partnerships covering several government entities, the firm’s leading product protects against smallpox bioterror attacks.

SIGA Technologies SIGA 

SIGA is trading higher than it did a year ago, ebbing and flowing much like any normal stock. After a recent selloff, the stock is rising on positive news and organically increasing its value in the wake of the aforementioned selloff.

Why is SIGA Moving?

SIGA is currently on the move because it has offered TPOXX as a treatment option for Monkeypox cases that have occurred in the UK. The firm exhibits both its compassion and advanced technology when assisting in these cases.

Where to Buy SIGA Technologies Stock

You can invest in SIGA Technologies using any of the brokers listed below. This list is curated by Benzinga to ensure your satisfaction and success.
 

Stay Ahead of the Game on SIGA

You can use Benzinga Pro to stay ahead of the game on SIGA, ensuring that you have all the information you need. It is much easier to research stocks, bonds, crypto and other investments when you have Benzinga in your corner, helping you build wealth and live comfortably. 

Data for SIGA Technologies as of July 22, 2021

Summary of SIGA Technologies as of July 22, 2021:

• Price Change: $6.650 to $6.43
• 52 Week Low: $5.66
• 52 Week High: $8.10
• Market Cap: $505.833M
• P/E Ratio: 8.905
• Dividend Yield: -

Significant Dates for SIGA Technologies:

• Next Earnings Date: August 5, 2021
• Last Earnings Date: -
• Ex-Dividend Date: -
• Dividend Payment Date: -

Technical Data of SIGA Technologies as of July 22, 2021:

• RSI: 46.1918 ⮕ Bearish
• MACD: Signal Line (-0.1058) Under MACD (-0.2967) ⮕ Bearish
• Bollinger Bands: Price ($6.43), 20-Day SMA ($6.3411), Lower Band ($5.8040), Upper Band ($7.6110) ⮕ Neutral

The preceding post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Although the piece is not and should not be construed as editorial content, the sponsored content team works to ensure that any and all information contained within is true and accurate to the best of their knowledge and research. This content is for informational purposes only and not intended to be investing advice.